Cargando…
In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen
Nowadays, the most advanced skin anti-aging treatments are addressed to restore the extracellular matrix (ECM) homeostasis. ECM is considered the main player not only as physical support of the tegument but also at the biochemical level, thanks to its capacity to exchange nutrients, water, cellular...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126805/ https://www.ncbi.nlm.nih.gov/pubmed/34012283 http://dx.doi.org/10.2147/CCID.S295618 |
_version_ | 1783693838104133632 |
---|---|
author | Rinaldi, Fabio Pinto, Daniela Trink, Anna Giuliani, Giammaria Sparavigna, Adele |
author_facet | Rinaldi, Fabio Pinto, Daniela Trink, Anna Giuliani, Giammaria Sparavigna, Adele |
author_sort | Rinaldi, Fabio |
collection | PubMed |
description | Nowadays, the most advanced skin anti-aging treatments are addressed to restore the extracellular matrix (ECM) homeostasis. ECM is considered the main player not only as physical support of the tegument but also at the biochemical level, thanks to its capacity to exchange nutrients, water, cellular mediators, and growth factors within and between cells. This study aimed to evaluate the in vitro and in vivo efficacy and aesthetic performance of a brand-new intracutaneous filler. The latter is based on novel concepts: besides filling it exerts a homeostatic balance of nutrients able to delay the skin aging process by sustaining physiological rejuvenation of the tissue and in the surrounding injection/implantation area. The brand-new intracutaneous filler was tested for in vitro capacity to stimulate extracellular matrix components production. Therefore, a single session for injection of the product under study was performed by a specialized dermatologist, using the bolus technique on the zygomatic protuberance of 20 healthy female subjects with midface volume loss, caused by aging. Results confirmed the important and long-term volumizing, anti-wrinkle, the hydrating activity of this product after one single injection session. The biological outcomes also support product effectiveness in skin structure restoration. |
format | Online Article Text |
id | pubmed-8126805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-81268052021-05-18 In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen Rinaldi, Fabio Pinto, Daniela Trink, Anna Giuliani, Giammaria Sparavigna, Adele Clin Cosmet Investig Dermatol Clinical Trial Report Nowadays, the most advanced skin anti-aging treatments are addressed to restore the extracellular matrix (ECM) homeostasis. ECM is considered the main player not only as physical support of the tegument but also at the biochemical level, thanks to its capacity to exchange nutrients, water, cellular mediators, and growth factors within and between cells. This study aimed to evaluate the in vitro and in vivo efficacy and aesthetic performance of a brand-new intracutaneous filler. The latter is based on novel concepts: besides filling it exerts a homeostatic balance of nutrients able to delay the skin aging process by sustaining physiological rejuvenation of the tissue and in the surrounding injection/implantation area. The brand-new intracutaneous filler was tested for in vitro capacity to stimulate extracellular matrix components production. Therefore, a single session for injection of the product under study was performed by a specialized dermatologist, using the bolus technique on the zygomatic protuberance of 20 healthy female subjects with midface volume loss, caused by aging. Results confirmed the important and long-term volumizing, anti-wrinkle, the hydrating activity of this product after one single injection session. The biological outcomes also support product effectiveness in skin structure restoration. Dove 2021-05-12 /pmc/articles/PMC8126805/ /pubmed/34012283 http://dx.doi.org/10.2147/CCID.S295618 Text en © 2021 Rinaldi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Clinical Trial Report Rinaldi, Fabio Pinto, Daniela Trink, Anna Giuliani, Giammaria Sparavigna, Adele In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen |
title | In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen |
title_full | In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen |
title_fullStr | In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen |
title_full_unstemmed | In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen |
title_short | In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen |
title_sort | in vitro and in vivo evaluation on the safety and efficacy of a brand-new intracutaneous filler with α1-r-collagen |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126805/ https://www.ncbi.nlm.nih.gov/pubmed/34012283 http://dx.doi.org/10.2147/CCID.S295618 |
work_keys_str_mv | AT rinaldifabio invitroandinvivoevaluationonthesafetyandefficacyofabrandnewintracutaneousfillerwitha1rcollagen AT pintodaniela invitroandinvivoevaluationonthesafetyandefficacyofabrandnewintracutaneousfillerwitha1rcollagen AT trinkanna invitroandinvivoevaluationonthesafetyandefficacyofabrandnewintracutaneousfillerwitha1rcollagen AT giulianigiammaria invitroandinvivoevaluationonthesafetyandefficacyofabrandnewintracutaneousfillerwitha1rcollagen AT sparavignaadele invitroandinvivoevaluationonthesafetyandefficacyofabrandnewintracutaneousfillerwitha1rcollagen |